Search
for
Sort by
Research 61–90 of 845
- Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine
- Langerin+ Dendritic Cells in Cutaneous Fibrosis: The TGF-β1 Signaling Axis
- Amelioration of psoriasis-like skin lesions by human amniotic mesenchymal stem cells: insights from multiomics profiling in mice
- Lichen Planopilaris and Frontal Fibrosing Alopecia as Model Epithelial Stem Cell Diseases
- Live Imaging of the Skin Immune Responses
- ESGCT and FSGT Collaborative Congress Helsinki, Finland September 17–20, 2015 Abstracts
- Mechanisms regulating skin immunity and inflammation
- Das weiße Hautfettgewebe initiiert die IL-33-abhängige Expression von Interleukin 4/13 in myeloischen Zellen während einer Entzündung
- Immunological control of skin development: from homeostasis to developmental pathologies
- Alopecia in Rhesus macaques correlates with immunophenotypic alterations in dermal inflammatory infiltrates consistent with hypersensitivity etiology
- Construction of regulatory network for alopecia areata progression and identification of immune monitoring genes based on multiple machine-learning algorithms
- Folliculotropic CD8+ mycosis fungoides associated with diffuse mucosal involvement
- Understanding Type 3 Innate Lymphoid Cells and Crosstalk with the Microbiota: A Skin Connection
- Unraveling the ECM-Immune Cell Crosstalk in Skin Diseases
- The immunology of the porcine skin and its value as a model for human skin
- An Overview of Growth Factors as the Potential Link between Psoriasis and Metabolic Syndrome
- Blank Spots in the Map of Human Skin: The Challenge for Xenotransplantation
- The Pathobiology of Skin Aging
- Regenerative Medicine-Based Treatment for Vitiligo: An Overview
- Cutaneous Neuroimmune Interactions in Peripheral Neuropathic Pain States
- Intestinal Intraepithelial Lymphocytes: Sentinels of the Mucosal Barrier
- Fibroblasts: Origins, definitions, and functions in health and disease
- Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
- SARS-CoV-2 vaccination in androgen sensitive phenotypes – A study on associated factors for SARS-CoV-2 vaccination and its adverse effects among androgenetic alopecia and benign prostate hyperplasia patients
- 331 An open label clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Transcriptomics analysis reveals molecular alterations underpinning spaceflight dermatology
- Treatment of frontal fibrosing alopecia: literature review 2020-2025
- Transcriptome Profiling and Differential Gene Expression in Canine Microdissected Anagen and Telogen Hair Follicles and Interfollicular Epidermis
- 186 Mechanistic insights into Ritlecitinib-mediated immunomodulation in Alopecia Areata
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway